Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.62 |
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.62 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CRHBP | P24387 | 2/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15429553 | 0.83 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1NUDT1HSD17B10MAPT | |
| SCHEMBL5367782 | 0.82 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1NUDT1HSD17B10MAPT | |
| SCHEMBL27029868 | 0.77 | KMT2A (0.45) | HSP90AA1HSP90AB1MAPTNPC1RAB9A | |
| SCHEMBL5361699 | 0.77 | HSP90AA1 (1.00) | HSP90AA1HSP90AB1NUDT1HSD17B10CYP1A2 | |
| SCHEMBL27269562 | 0.75 | HSP90AA1 (0.34) | HSP90AA1HSP90AB1 | |
| SCHEMBL151114 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL20919221 | 0.71 | HSP90AA1 (0.56) | HSP90AA1HSP90AB1NUDT1MAPTCYP1A2 | |
| SCHEMBL30863954 | 0.71 | HSP90AA1 (0.56) | HSP90AA1HSP90AB1NUDT1MAPTCYP1A2 | |
| SCHEMBL27651209 | 0.71 | HSP90AA1 (0.56) | HSP90AA1HSP90AB1NUDT1MAPTCYP1A2 | |
| SCHEMBL150686 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140005172-A1 | Benzoxazepines as Inhibitors of PI3K/M TOR and Methods of Their Use and Manufacture | ELELIXIS, INC. (US) | 2014-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140005172-A1 | Benzoxazepines as Inhibitors of PI3K/M TOR and Methods of Their Use and Manufacture | MTOR, RICTOR, PIK3R2 | HSP90AA1 1580/4885HSP90AB1 829/4885NUDT1 3805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.